Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.44 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.44 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | RGS12 | O14924 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14441259 | 1.00 | SLC7A5 (0.44) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL1640222 | 1.00 | SLC7A5 (0.44) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL14023473 | 0.84 | SLC7A5 (0.41) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL1076502 | 0.74 | SLC7A5 (0.44) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL3278753 | 0.74 | SLC7A5 (0.41) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL6009735 | 0.71 | USP2 (0.42) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL23996206 | 0.71 | MAPT (0.39) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL29280376 | 0.70 | SLC7A5 (0.46) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL4994581 | 0.70 | SLC7A5 (0.46) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL25737316 | 0.69 | SLC7A5 (0.37) | SLC7A5PKMPTGS1ALPIXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11578106-B2 | Surfactant adhesive composition | TME Therapeutics Co., Ltd. (KR) | 2023-02-14 | — | — | US | claimed |
| CN-115068664-A | Bioadhesive compositions comprising mussel adhesive proteins and methods of making the same | 浦项工科大学校产学协力团 | 2022-09-20 | — | — | CN | claimed |
| US-6335468-B1 | CONDENSING N-ACYL AMINO ACID OR SALT THEREOF WITH AMINE AND/OR AMMONIA UNDER DEHYDRATING CONDITIONS IN PRESENCE OF BORON COMPOUND AS CATALYST WITH ALCOHOL COEXISTENT AS AUXILIARY SOLVENT | AJINOMOTO CO., INC. (JP) | 2002-01-01 | — | — | US | claimed |
| US-12577287-B2 | T cell receptors and methods of use thereof | UNIVERSITY HEALTH NETWORK (CA) | 2026-03-17 | — | — | US | disclosed |
| US-20260070944-A1 | PEPTIDE PROMOTING TYROSINASE ACTIVITY AND USE THEREOF | HYSENSBIO CO., LTD (KR) | 2026-03-12 | — | — | US | disclosed |
| US-20260048001-A1 | SKINCARE COMPOSITION CONTAINING CASHEW APPLE EXTRACT | R & D GLOBAL CONSULTANTS PVT LTD (IN) | 2026-02-19 | — | — | US | disclosed |
| EP-4582095-A1 | PEPTIDE FOR PROMOTING TYROSINASE ACTIVITY AND USE THEREOF | Hysensbio Co., Ltd (KR) | 2025-07-09 | — | — | EP | disclosed |
| CN-119866225-A | Peptides promoting tyrosinase activity and uses thereof | 株式会社海森斯柏奥 | 2025-04-22 | — | — | CN | disclosed |
| WO-2025071094-A1 | USES OF MERCAPTO FUNCTIONAL COMPOUND HAVING TYROSINASE INHIBITORY ACTIVITY | 부산대학교 산학협력단 | 2025-04-03 | — | — | WO | disclosed |
| EP-4288102-B1 | LAYERED STRUCTURE FOR SPECIFIC CELL CAPTURING | UNIV BERLIN FREIE (DE) | 2025-04-02 | — | — | EP | disclosed |
| CN-119326697-B | Preparation and application of umbilical cord extract with hair blackening effect by regulating hair follicle melanocyte to produce melanin granule | 广州优特佳生物科技发展有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-5210076-A | Methods of treating Parkinson's disease using melanin | LARGE SCALE BIOLOGY CORPORATION | 1993-05-11 | — | — | US | disclosed |
| EP-0510186-A4 | THERAPEUTIC USES OF MELANIN | — | 1993-03-24 | — | — | EP | disclosed |
| WO-1993002682-A1 | METHOD AND COMPOSITIONS FOR REDUCING CRAVING FOR ALCOHOL AND STIMULANTS | LABCO PHARMACEUTICALS, INC. (US) | 1993-02-18 | — | — | WO | disclosed |
| EP-0510186-A1 | THERAPEUTIC USES OF MELANIN | Biosource Technologies, Inc. (US) | 1992-10-28 | — | — | EP | disclosed |
| WO-1992007580-A1 | THERAPEUTIC USES OF MELANIN | BIOSOURCE GENETICS CORPORATION (US) | 1992-05-14 | — | — | WO | disclosed |
| EP-0434750-A1 | PROPHYLAXIS AND TREATMENT OF NERVOUS SYSTEM DISEASES WITH MELANIN. | BIOSOURCE GENETICS CORP (US) | 1991-07-03 | — | — | EP | disclosed |
| WO-1990002551-A2 | PROPHYLAXIS AND TREATMENT OF NERVOUS SYSTEM DISEASES WITH MELANIN | BIOSOURCE GENETICS CORPORATION (US) | 1990-03-22 | — | — | WO | disclosed |
| US-4718994-A | HYDROXYLATION | LATVIISKY GOSUDARSTVENNY UNIVERSAITET IMENI P. STUCHKI (SU) | 1988-01-12 | — | — | US | disclosed |
| US-4181527-A | HYDROPHILIC COLLOID | FUJI PHOTO FILM CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048001-A1 | SKINCARE COMPOSITION CONTAINING CASHEW APPLE EXTRACT | EP300, SCD, COL2A1 | SLC7A5 1443/4885PKM 3595/4885PTGS1 995/4885 |
| US-20260070944-A1 | PEPTIDE PROMOTING TYROSINASE ACTIVITY AND USE THEREOF | TYR, ARGLU1, ARG1 | SLC7A5 406/4885PKM 1234/4885PTGS1 3205/4885 |
| US-12577287-B2 | T cell receptors and methods of use thereof | MICA, TAP1, TAP2 | SLC7A5 3447/4885PKM 4875/4885PTGS1 4699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.